Adenosine and Inflammation: Here, There and Everywhere.

Existing knowledge shows that adenosine modulates inflammation through G protein-coupled receptors. It was already known that adenosine receptors are widely expressed in immune and non-immune cells. However, the full scope of adenosine's role in various inflammatory contexts remains unclear. This gap motivated researchers to explore how adenosine affects multiple disease states. No prior work had resolved the dual nature of adenosine as both a protective and harmful factor in inflammation. Understanding these mechanisms could lead to new therapeutic strategies. The field lacks a comprehensive review of adenosine's role in inflammation across different tissues. This paper provides a synthesis of current evidence on adenosine's involvement in inflammation.

The aim of this study was to evaluate the role of adenosine in modulating inflammation across various disease contexts. Researchers focused on how adenosine receptors influence immune responses. They sought to clarify the therapeutic potential of targeting these receptors. The study aimed to highlight the complexity of adenosine signaling in inflammation. This work addresses the need for a unified understanding of adenosine's effects. The authors aimed to identify promising strategies for treating chronic inflammatory diseases. They also examined adenosine's role in neurodegenerative and cancer-related inflammation. The purpose was to guide future research and drug development in this area.

This review analyzed existing literature on adenosine and inflammation. The authors focused on the four adenosine receptor subtypes and their functions. They examined how each receptor subtype contributes to inflammatory responses. The study included data from preclinical and clinical investigations. Researchers synthesized findings on adenosine's role in immune cell signaling. They reviewed studies on adenosine's effects in chronic and acute inflammation. The authors compared the pharmacological profiles of adenosine receptor ligands. The review approach emphasized the therapeutic implications of adenosine modulation.

The strongest finding is that adenosine modulates inflammation through multiple receptor subtypes. A₁ receptors are linked to anti-inflammatory effects in immune cells. A_2A receptors promote anti-inflammatory responses in macrophages and T cells. A_2B receptors are associated with pro-inflammatory effects in certain contexts. A₃ receptors have complex roles in both pro- and anti-inflammatory pathways. Adenosine's extracellular concentration is a key regulator of immune responses. The study showed that modulating adenosine levels can influence disease progression. These findings suggest that adenosine receptor ligands may offer therapeutic benefits.

The authors propose that adenosine receptors are promising targets for treating inflammatory diseases. They suggest that receptor-specific ligands could improve therapeutic outcomes. The review highlights the importance of understanding adenosine's dual effects. The synthesis of evidence shows that adenosine signaling is tissue- and context-dependent. The authors emphasize the need for targeted approaches in drug development. They note that adenosine's role in neurodegenerative and cancer-related inflammation is significant. The findings support further research into adenosine-based therapies. The review concludes that adenosine's modulation offers potential for multiple disease states.